The Combination of Zerumbone and 5-FU: A Significant Therapeutic Strategy in Sensitizing Colorectal Cancer Cells to Treatment
Objectives. Chemotherapy is considered to be essential in the treatment of patients with colorectal cancer (CRC), but drug resistance reduces its efficacy. Many patients with advanced CRC eventually show resistance to 5-fluorouracil (5-FU) therapy. Synergistic and potentiating effects of combination...
Main Authors: | Razieh Dehghan, Fatemeh Bahreini, Rezvan Najafi, Massoud Saidijam, Razieh Amini |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2021/6635874 |
Similar Items
-
Cross-Resistance of Acquired Radioresistant Colorectal Cancer Cell Line to gefitinib and regorafenib
by: Saeid Afshar, et al.
Published: (2020-01-01) -
Co-regulatory Network of Transcription Factors and miRNAs in Colorectal Cancer Pathogenesis
by: Mohammad Hasan Soheilifar, et al.
Published: (2020-09-01) -
LEF1 silencing sensitizes colorectal cancer cells to oxaliplatin, 5-FU, and irinotecan
by: Elham Fakhr, et al.
Published: (2021-11-01) -
Angioregulatory microRNAs in Colorectal Cancer
by: Mohammad Hasan Soheilifar, et al.
Published: (2019-12-01) -
Combined Therapeutic Effects of 131I-Labeled and 5Fu-Loaded Multifunctional Nanoparticles in Colorectal Cancer
by: Wu P, et al.
Published: (2020-04-01)